Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „approved“
Suchtreffer
Begriffe & Kennungen
MabThera · 4.8 · The safety profile of MabThera in PV was consistent with the established safety profile in other approved auto
Eintrag öffnenMatever · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenMatever · 4.8 · The adverse reaction profile of levetiracetam is generally similar across age groups and across the approved e
Eintrag öffnenMvasi · 4.8 · MVASI is not approved for use in patients under the age of 18 years. In published literature reports, cases of
Eintrag öffnenNovoSeven · 4.8 · Safety and efficacy of NovoSeven have not been established outside the approved indications and therefore Novo
Eintrag öffnenNovoSeven · 4.8 · When NovoSeven is administered to patients outside approved indications, arterial thromboembolic events are co
Eintrag öffnenOsenvelt · 4.8 · Overall safety profile is consistent in all approved indications for denosumab.
Eintrag öffnenOyavas · 4.8 · Oyavas is not approved for use in patients under the age of 18 years. In published literature reports, cases o
Eintrag öffnenRatiograstim · 4.8 · There is insufficient data to evaluate filgrastim use in geriatric subjects for other approved filgrastim indi
Eintrag öffnenRixathon · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenRixathon · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenRiximyo · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenRiximyo · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenRuxience · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenRuxience · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenTevagrastim · 4.8 · There is insufficient data to evaluate filgrastim use in geriatric subjects for other approved filgrastim indi
Eintrag öffnenTruxima · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenTruxima · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenVegzelma · 4.8 · Vegzelma is not approved for use in patients under the age of 18 years. In published literature reports, cases
Eintrag öffnenVevzuo · 4.8 · Overall safety profile is consistent in all approved indications for Vevzuo.
Eintrag öffnen